Elucidating the mechanisms underlying how TROP2 expression and signalling modulates the molecular and cellular programs of CRC cells and promotes their metastatic progression would help to improve CRC metastasis therapies. This evidence concerns the gene TACSTD2 and colorectal carcinoma.